Hosted on MSN
Lexicon outlines 2026 milestones as SONATA-HCM enrollment surpasses 50% and cash position is strengthened
Michael Exton, CEO, highlighted, "Lexicon is advancing 3 very strong novel late-stage programs in the therapeutic areas of cardiometabolic disease and chronic pain." He emphasized progress in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results